Forbion Capital Fund IV Cooperatief U.A. sold $1.9M of NewAmsterdam Pharma (NAMS)

Executed Dec 26 2024, disclosed Dec 30 2024, 4 days later.

Value, as filed

$1.9M

74,910 sh across 2 lots

Executed

Dec 26 2024

the trade date, as filed

Disclosed

Dec 30 2024

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

FA Forbion Capital Fund IV Cooperatief U.A. 10% owner profile →

Forbion Capital Fund IV Cooperatief U.A. (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 2 sales), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $1.9M of NAMS (74,910 sh across 2 lots, as filed), executed Dec 26 2024.

The name

NAMS

NewAmsterdam Pharma Company N.V. NAMS · Healthcare · 45 filings in 24 months ticker →

Healthcare · NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with ca…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Forbion Capital Fund IV Cooperatief U.A. in NAMS

NAMSSALE NewAmsterdam Pharma Company N.V. $246K
9,832 sh × $25.01
Exec Nov 14 2024
Filed Nov 15 2024 · 5:30 PM ET